Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of staphylococcus aureus and antibody to TSST-1 among healthy Japanese women

Journal of Clinical Microbiology

Volumn 46, Issue 8, 2008, Pages 2731-2738

  Parsonnet, Jeffrey ^a   Goering, Richard V ^b   Hansmann, Melanie A ^c   Jones, Michaelle B ^c   Ohtagaki, Kumiko ^c   Davis, Catherine C ^c   Totsuka, Kyoichi ^d  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PROCTER AND GAMBLE COMPANY   (United States)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TOXIC SHOCK SYNDROME TOXIN 1; TOXIN ANTIBODY; BACTERIAL DNA; BACTERIAL TOXIN; BACTERIUM ANTIBODY; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL; SUPERANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CAUCASIAN; CLONE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE; HUMAN; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME; UNITED STATES; VAGINA; ADOLESCENT; BIOSYNTHESIS; BLOOD; CLASSIFICATION; CLUSTER ANALYSIS; COMPARATIVE STUDY; DNA FINGERPRINTING; DNA SEQUENCE; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED;

STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; CARRIER STATE; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROTOXINS; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PREVALENCE; SEQUENCE ANALYSIS, DNA; SEROEPIDEMIOLOGIC STUDIES; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TOKYO; UNITED STATES;

EID: 53149126147     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00228-08     Document Type: Article

References (54)

1. Adesiyun, A. A., D. Singh, and R. I. Gunness. 1994. Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad. Zentralbl. Bakteriol. 280:371-381.
2. Azuma, M. 1999. A case of menstrual toxic shock syndrome possibly caused by methicillin-resistant Staphylococcus aureus (MRSA). Kansenshogaku Zasshi 73:267.
3. Centers for Disease Control and Prevention. 30 April 2004. Summary of notifiable diseases - United States. Morbid. Mortal. Wkly. Rep. 51:1-84.
4. Chow, A. W., K. H. Bartlett, R. Percival-Smith, and B. J. Morrison. 1984. Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J. Infect. Dis. 150: 80-84.
5. Clinical and Laboratory Standards Institute. 2008. Performance standards for antimicrobial susceptibility testing; 18th informational supplement. M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Cui, L., H. Kasegawa, Y. Murakami, H. Hanaki, and K. Hiramatsu. 1999. Postoperative toxic shock syndrome caused by a highly virulent methicillin-resistant Staphylococcus aureus strain. Scand. J. Infect. Dis. 31:208-209.
7. Davis, C. C., M. J. Kremer, P. M. Schlievert, and C. A. Squier. 2003. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am. J. Obstet. Gynecol. 189:1785-1791.
8. de Saxe, M. J., P. Hawtin, and A. A. Wieneke. 1985. Toxic shock syndrome in Britain - epidemiology and microbiology. Postgrad. Med. J. 61(Suppl. 1):5-21.
9. DeVries, A., L. Lesher, T. Rogers, R. Danila, and R. Lynfield. 2007. Incidence of staphylococcal toxic shock syndrome 2000-2003, abstr. 269. 45th Annu. Meet. Infect. Dis. Soc. Am.
10. Dickgiesser, N., and B. Kustermann. 1987. IgG antibodies to toxic shock syndrome toxin-1 (TSST-1) in human sera. Wien. Klin. Wochenschr. 65:256-258. (In German.)
11. Enright, M. C., N. P. J. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
12. Fey, P. D., B. Saïd-Salim, M. E. Rupp, S. H. Hinrichs, D. J. Boxrud, C. C. Davis, B. N. Kreiswirth, and P. M. Schlievert. 2003. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:196-203.
13. Fujiwara, Y., and S. Endo. 2001. A case of toxic shock syndrome secondary to mastitis caused by methicillin-resistant Staphylococcus aureus. Kansenshogaku Zasshi 75:898-903.
14. Gaventa, S., A. L. Reingold, A. W. Hightower, C. V. Broome, B. Schwartz, C. Hoppe, J. Harwell, L. K. Lefkowitz, S. Makintubee, and D. R. Cundiff. 1989. Active surveillance for toxic shock syndrome in the United States, 1986. Rev. Infect. Dis. 11(Suppl. 1):S28-S34.
15. Goering, R. V. 2004. Pulsed field gel electrophoresis. In D. H. Persing, F. C. Tenover, J. Versalovic, Y. Tank, B. Unger, D. Relman, and T. J. White (ed.), Molecular microbiology: diagnostic principles and practice. ASM Press, Washington, DC.
16. Gustafson, T. L., G. L. Swinger, A. L. Booth, R. H. Hutcheson, Jr., and W. Schaffner. 1982. Survey of tampon use and toxic shock syndrome, Tennessee, 1979 to 1981. Am. J. Obstet. Gynecol. 143:369-374.
17. Hajjeh, R. A., A. Reingold, A. Weil, K. Shutt, A. Schuchat, and B. A. Perkins. 1999. Toxic shock syndrome in the United States: surveillance update, 1979-1996. Emerg. Infect. Dis. 5:807-810.
18. Hisata, K., K. Kuwahara-Arai, M. Yamanoto, T. Ito, Y. Nakatomi, L. Cui, T. Baba, M. Terasawa, C. Stozono, S. Kinoshita, Y. Yamashiro, and K. Hiramatsu. 2005. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J. Clin. Microbiol. 43:3364-3372.
19. Ishi, K. 2001. A case report of menstrual toxic shock syndrome caused by toxin producing Staphylococcus aureus isolated from vaginal fluid. Acta Obstet. Gynaecol. Jpn. 53:659-663.
20. Ishihara, T., Y. Yanase, and H. Igarashi. 1987. A case of toxic shock syndrome from which TSST producing Staphylococcus aureus was isolated from a tampon and vaginal fluid. Kansenshogaku Zasshi 61:619-623.
21. Jacobson, J. A., E. M. Kasworm, B. A. Crass, and M. S. Bergdoll. 1986. Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah. J. Infect. Dis. 153:356-359.
22. Kikuchi, K., N. Takahashi, C. Piao, K. Totsuka, H. Nishida, and T. Uchiyama. 2003. Molecular epidemiology of methicillin-resistant Staphylococcus aureus strains causing neonatal toxic shock syndrome-like exanthematous disease in neonatal and perinatal wards. J. Clin. Microbiol. 41:3001-3006.
23. Kitamura, T. 1988. A possible case of toxic shock syndrome. Rinsho To Kenkyu 65:3191-3194.
24. Linnemann, C. C., Jr., J. L. Staneck, S. Hornstein, T. P. Barden, J. L. Rauh, P. F. Bonventre, C. R. Buncher, and A. Beiting. 1982. The epidemiology of genital colonization with Staphylococcus aureus. Ann. Intern. Med. 96:940-944.
25. Loch, E. G., B. A. Crass, and M. S. Bergdoll. 1986. Staphylococcus aureus - toxic shock syndrome toxin-1 antibody titers in serum of German women. Arch. Gynecol. 237:229-233.
26. McDougal, L. K., C. D. Steward, G. E. Killgore, J. M. Chaitram, S. K. McAllister, and F. C. Tenover. 2003. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120.
27. Meyer, R. D., S. R. Monday, G. A. Bohach, and S. M. Schlievert. 2001. Prolonged course of toxic shock syndrome associated with methicillin-resistant Staphylococcus aureus enterotoxins G and I. Int. J. Infect. Dis. 5:163-166.
28. Monday, S. R., and G. A. Bohach. 1999. Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates. J. Clin. Microbiol. 37:3411-3414.
29. Nakano, M., H. Miyazawa, Y. Kawano, M. Kawagishi, K. Torii, T. Hasegawa, Y. Iinuma, and M. Ohta. 2002. An outbreak of neonatal toxic shock syndrome-like exanthematous disease (NTED) caused by methicillin-resistant Staphylococcus aureus (MRSA) in a neonatal intensive care unit. Microbiol. Immunol. 46:277-284.
30. Narita, K., D.-L. Hu, T. Tsuji, and A. Nakane. 2008. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection. FEMS Immunol. Med. Microbiol. 52:389-396.
31. Ochiai, K., S. Isonishi, M. Murae, K. Kusuhara, and S. Hachiya. 1983. Toxic shock syndrome (TSS) - report of 2 cases and a study on vaginal flora and sanitary products used during menstruation. Nippon Sanka Fujinka Gakkai Zasshi 35:1689-1692.
32. Okada, T., S. Furukawa, K. Miwa, R. Sakai, and J. Sugiyama. 1999. A new exanthematous disease in newborn infants caused by exotoxins producing Staphylococcus aureus; exotoxins production of the isolates and serum levels of antitoxin antibody in the patients and umbilical cord blood. Kansenshogaku Zasshi 73:893-900.
33. Okada, T., A. Makimoto, A. Kitamura, S. Furukawa, K. Miwa, and R. Sakai. 2000. A new exanthematous disease in newborn infants caused by exotoxins producing methicillin-resistant Staphylococcus aureus; pathology from view-points of local and systemic levels of exotoxin and cytokine. Kansenshogaku Zasshi 74:573-579.
34. Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.
35. Ota, K. 2000. A case of toxic shock syndrome (TSS) possibly caused by enterotoxin-B, p. 24. Abstr. 486th Kanto Reg. Meet. Jpn. Soc. Int. Med.
36. Parsonnet, J., M. A. Hansmann, M. L. Delaney, P. A. Modern, A. M. DuBois, W. Wieland-Alter, K. W. Wissemann, J. E. Wild, M. B. Jones, J. L. Seymour, and A. B. Onderdonk. 2005. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J. Clin. Microbiol. 43:4628-4634.
37. Parsonnet, J., M. Delaney, A. Dubois, P. Modern, W. Weiland-Alter, M. Hansmann, J. Seymour, J. Wild, and A. Onderdonk. 2002. Persistence of toxic shock syndrome toxin-1 (TSST-1)-producing Staphylococcus aureus & antibody (Ab) to TSST-1, abstr. B-1437, p. 58. Abstr. 42nd Intersci. Conf. Antimicrob. Agents Chemother., San Diego, CA.
38. Parsonnet, J., J. T. Mills, Z. A. Gillis, and G. B. Pier. 1985. Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin-1. J. Clin. Microbiol. 22:26-31.
39. Parsonnet, J., C. Sullivan, P. Modern, and K. Wissemann. 1997. Risk factors for TSS among European women: vaginal colonization with S. aureus and antibody to TSST-1, p. 72. In J. Arbuthnott and B. Furman (ed.), European conference on toxic shock syndrome: proceedings of a symposium sponsored by Procter & Gamble. Royal Society of Medicine Press, London, United Kingdom.
40. Piao, C., T. Karasawa, K. Totsuka, T. Uchiyama, and K. Kikuchi. 2005. Prospective surveillance of community-onset and healthcare-associated methicillin-resistant Staphylococcus aureus isolated from a university-affiliated hospital in Japan. Microbiol. Immunol. 49:959-970.
41. Reingold, A. L., N. T. Hargrett, K. N. Shands, B. B. Dan, G. P. Schmid, B. Y. Strickland, and C. V. Broome. 1982. Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann. Intern. Med. 96:875-880.
42. Roithmann, R. 2007. Specific tests for nasal permeability. Rev. Bras. Otorrinolaringol. 73:2.
43. Schroder, E., G. Kunstmann, H. Hasbach, and G. Pulverer. 1988. Prevalence of serum antibodies to toxic-shock-syndrome-toxin-1 and to staphylococcal enterotoxins A, B and C in West-Germany. Zentralbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 270:110-114.
44. Shands, K. N., G. P. Schmid, B. B. Dan, D. Blum, R. J. Guidotti, N. T. Hargrett, R. L. Anderson, D. L. Hill, C. V. Broome, J. D. Band, and D. W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical feature in 52 cases. N. Engl. J. Med. 303:1436-1442.
45. Shibuya, N. 2003. A case of TSS-like clinical condition - microbiological study on menstrual tampon and speculation about actual usage status. J. Dermatol. 113:748.
46. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
47. Stokes, M. E., C. S. Davis, and G. S. Koch. 1995. Categorical data analysis using the SAS system. SAS Institute Inc., Gary, NC.
48. Takahashi, N. 2003. Neonatal toxic shock syndrome-like exanthematous disease (NTED). Pediatr. Int. 45:233-237.
49. Takahashi, N., H. Nishida, M. Ino, Y. Sakata, I. Sakuma, and Y. Takeda. 1995. A new exanthematous disease in newborn infants. Acta Neonat. Jpn. 31:371-377.
50. Tanaka, S., Y. Takemoto, H. Ono, and C. Fuji. 1983. Probable case of toxic shock syndrome. Kansenshogaku Zasshi 57:448-453.
51. Totsuka, K., M. Shiseki, K. Kikuchi, and Y. Matsui. 1999. Combined effects of vancomycin and imipenem against methicillin-resistant Staphylcoccus aureus (MRSA) in vitro and in vivo. J. Antimicrob. Chemother. 44:455-460.
52. Ueda, S., and Y. Kuwabara. 1992. Enterotoxicogenicity of Staphylococcus aureus strains from healthy women's fingers. J. Antibact. Antifung. Agents 20:313-316.
53. Uemura, E., S. Kakinohana, N. Higa, C. Toma, and N. Nakasone. 2004. Comparative characterization of Staphylococcus aureus isolates from throats and noses of healthy volunteers. Jpn. J. Infect. Dis. 57:21-24.
54. Watelet, J. B., and P. Van Cauwenberge. 1999. Applied anatomy and physiology of the nose and paranasal sinuses. Allergy 54(Suppl. 57):14-25.